Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Intraoperative Radiation Therapy (IORT) in Gynecologic Cancers: A Scoping Review
Erdemoğlu, Evrim , Ostby, Stuart A. , Senthilkumar, Sanjanaa , Kumar, Amanika , Vora, Sujay A., James, Sarah E. , Butler, Kristina , Butler, Kristina A., Kumar, Amanika , Chen, Longwen

Mayo Clinic

Cancers | April 20, 2025 | Volume: 17 | Issue: 8 | Pages: 1356

10.3390/cancers17081356 | PMID 40282536 Get It

Objective: We aimed to analyze the current literature for IORT in gynecological cancers and summarized clinical outcomes regarding patient selection. Methods: A systematic search was conducted utilizing PUBMED, Embase, and CINAHL to identify studies following PRISMA-ScR guidelines. A PICOS structure was utilized: population: patients with epithelial gynecological cancers; intervention: IORT; C: a comparator was not required, as we aimed to analyze patient selection; outcome: clinical outcomes and overall survival; and S: experimental and quasi-experimental analytical observational studies and descriptive observational studies, excluding case series published in English and limited to the last 10 years. Data extraction was conducted for patient selection, IORT, oncological outcomes, and morbidity. Results: A total of 707 results were identified, and 509 studies were uploaded to Covidence for screening after removing duplications. Of the 21 eligible studies, 9 were included in the final review. The total number of patients included was 348. The studies were retrospective single-institution studies, except for one. There was significant heterogeneity in their design and protocols. IORT was exclusively used for recurrent and advanced stage gynecological cancers adjunct to pelvic exenteration or laterally extended endopelvic resections with variable indications across institutions. The mean number of IORT patients per study was 2.8 per year. Survival rates were variable and dependent on the surgical margin. Endometrial cancer had a favorable outcome compared to vulvar and cervical cancers. Conclusions: Current clinical practice, as demonstrated by the research, is consistent with NCCN guidelines that endorse the application of IORT in instances of recurrent cervical, vaginal, and vulvar malignancies; however, there are no established recommendations for primary tumors. The analysis shows that there are gaps in our knowledge, mainly regarding the status of the margins, the criteria used to choose patients, and the outcomes that are specific to each histology. The standardization of protocols and prospectively powered studies are needed to refine patient selection criteria.
Enhancing nurse recognition and intervention of caregiver fatigue in the pediatric intensive care unit: a quality improvement project
Monson, Amanda J., Mujic, Anna, Breslin, Maggie , Prochnow, J., Rhudy, Lori M. , McCarthy, Sarah , McCarthy, Sarah R. , Monson, Amanda, McCarthy, Sarah R , Mujic, Anna J., Prochnow, Jen, McCarthy, Sarah R.

Mayo Clinic

Journal of Pediatric Psychology | April 18, 2025 | Volume: 51 | Issue: 3 | Pages: 212-220

10.1093/jpepsy/jsaf039 | PMID 40729304 Get It

Abstract Objective This QI project aimed to enhance pediatric intensive care unit (PICU) staff’s ability to recognize and compassionately respond to caregiver fatigue (CF), tailoring interventions to the specific needs identified. Methods An interdisciplinary team of healthcare professionals developed and implemented a comprehensive strategy to improve the recognition and management of CF. This QI project included creating educational materials for staff, enhancing unit resources, and introducing targeted interventions. Data collection involved pre- and post-project surveys. Results The program led to significant improvements in PICU staff’s confidence in recognizing and responding to CF, increased availability of unit resources, enhanced staff compassion, and reduced callousness toward others. Conclusions This QI project emphasized the role that structured initiatives and interdisciplinary collaboration can play in addressing CF within the PICU setting. Improvements in staff confidence, compassion, and reduced burnout demonstrate the program’s effectiveness. These findings underscore the value of targeted interventions and provide a valuable framework for further research and can serve as a model for other healthcare units seeking to integrate CF management into comprehensive patient care.
Pineal parenchymal tumor of intermediate differentiation: Case series and literature review: Is it time for a consensus?
Srinivasan, Siddharth , Jampani, Ravi Teja, Chigurupati, Dhanwanth, Raju, Bharat , Subramanian, Susanth , Baxi, Udgam, Kanneganti, Yasaswi, Johnson, Sarah H. , Nayal, Bhavna, Vasudevan, Geetha , M, Deepak Nayak , Johnson, Sarah, Hegde, Ajay , Nair, Rajesh Parameshwaran , Ashraf, Mohammad, Menon, Girish

Mayo Clinic

Surgical Neurology International | April 18, 2025 | Volume: 16 | Issue: No issue available | Pages: 138

10.25259/sni_1068_2024 | PMID 40353160 Get It

Background Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare tumor. This study aims to evaluate patient outcomes and propose a treatment algorithm based on existing literature and our case series. Methods This prospective observational study includes seven patients diagnosed with PPTID through histopathology. We analyzed their clinical presentation, magnetic resonance imaging findings, surgical approaches, histopathological and immunohistochemical analysis, adjuvant treatments, and outcomes. We conducted univariate and multivariate statistical analyses. Results The mean patient age was 40 years, with a male predominance. All patients presented with hydrocephalus, four of which required cerebrospinal fluid diversion procedures. The average tumor size was 3.13cm, with 85.7% showing brain invasion. Surgical outcomes included one gross total resection, two near total resections, and four subtotal resections. The supracerebellar infratentorial (Krause) approach was used in 71.4% of cases. About 85.7% were diagnosed with grade 3 PPTID. Five patients received adjuvant radiotherapy. The analysis showed each additional mitosis unit decreased survival by 0.17 units, equating to roughly 2 months (P < 0.016). Follow-up ranged from 6 to 120 months, with a 5-year survival rate of 57.1%. Factors influencing survival included the extent of tumor resection, brain invasion, tumor grade, and adjuvant treatment, although it was not statistically significant due to the small sample size. Conclusion We propose a treatment algorithm for PPTID and highlight the importance of further research to understand its biological characteristics. Safe maximal resection appears beneficial for higher-grade PPTID, but the role of adjuvant treatment after complete resection of lower-grade tumors remains uncertain.
A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support Women's Health
Greene, Dina N. , Daccarett, Sarah, Lorey, Thomas , Rytz, Chantal L. , Smock, Kristi J. , Winston‐McPherson, Gabrielle , Lorey, Thomas S , Smock, Kristi J , Greene, Dina , Ahmed, Sofia Bano , Daccarett, Sarah, Kling, Juliana M.

Mayo Clinic

Clinical Chemistry | April 18, 2025 | Volume: 71 | Issue: 8 | Pages: 842-857

10.1093/clinchem/hvaf039 | PMID 40247783 Get It

Abstract Background There have been conflicting messages about the influence of female sex hormones on women's health, with historical messaging indicating that use of estrogen and/or progesterone in peri- or postmenopause poses a significant clinical risk to cisgender women. More recent guidance indicates that the benefit of hormone therapy (HT) outweighs the risks for symptomatic women. Exogenous estrogen use is also indicated for contraception and gender-affirming care. Despite the potential for broad applications, robust reference intervals for estradiol, progesterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are lacking, and guidelines indicate that measurement of 17-β-estradiol (E2), progesterone, LH, or FSH does not facilitate care in women who may be experiencing menopausal symptoms or women taking exogenous HT. Content Here we review the physiological roles of estrogen, progesterone, LH, and FSH. We examine the modes of administration for estrogen and progesterone, clarify the nomenclature related to exogenous hormone use, and comprehensively review the literature for studies evaluating normal concentrations of these female gonadal axis hormones during the menstrual cycle. The content primarily focuses on cisgender women, but some aspects of these hormones in transgender women will also be discussed. Summary Currently, E2, LH, FSH, and progesterone reference intervals for women remain incomplete. Although there are a variety of clinical indications that benefit women using HT, symptoms and shared decision-making should guide care. Collaborative efforts between clinicians and laboratory professionals to better define therapeutic or reference intervals for these hormones can advance women's health globally.
Burnout and career satisfaction among urologists specializing in sexual health
Schrup, Sarah E. , Hanley, Meg , May, Emily , Jones, James M. , Ziegelmann, Matthew , Gross, Martin , Schrup, Sarah, Jones, James M

Mayo Clinic

The Journal of Sexual Medicine | April 15, 2025 | Volume: 22 | Issue: 5 | Pages: 869-876

10.1093/jsxmed/qdaf074 | PMID 40231422 Get It

Abstract Background While the rate of physician burnout has been characterized as relatively high among urologists compared to other specialties, a specific examination of burnout and predictors of burnout among urologists specializing in sexual medicine has not been conducted. Aim The aim of this study was to collect demographic characteristics of urologists specializing in sexual medicine, assess the occurrence of and risk factors for burnout, and characterize satisfaction with career, compensation and work-life balance. Methods We surveyed 96 urologists specializing in sexual medicine to characterize demographic and practice characteristics and assess their satisfaction with career aspects and levels of burnout. Univariable and multivariable modeling with stepwise variable selection was utilized to identify predictive variables of burnout. Outcomes The Copenhagen Burnout Inventory was used to assess personal burnout, work-related burnout, patient-related burnout, and overall burnout. Results Twenty-four percent (n = 23) of participants reported burnout with 35.4% (n = 34) reporting personal burnout, 38.5% (n = 37) reporting work-related burnout, and 24.0% (n = 23) reporting patient-related burnout. Younger age (P = 0.051), Black/African American or multiracial race compared to white race (P &lt; 0.0001), Latino or Hispanic background (P = 0.034), female sex (P = 0.059), being unmarried (P = 0.047), and increased educational debt (0.030) were identified as predictive of overall burnout in adjusted analysis. Dissatisfaction with work-life balance was significantly related to an increase in all categories of burnout (P &lt; 0.01). Clinical implications These findings may guide practice patterns and initiatives to support groups identified at increased risk of burnout, as well as function as a benchmark for future studies of burnout in the sexual medicine urology community. Strengths and limitations While this is the first study of burnout specifically among sexual medicine urologists and findings are consistent with the overall urology community, the small sample size may lead to a biased sample. Conclusion Several demographic and personal characteristics were identified to be predictive of burnout among the sexual medicine urology community, indicating opportunities for additional support.
Creating a Mammography Conversation Aid for Shared Decision‐Making Between Clinicians and Women Aged 75 and Older
Schonberg, Mara A. , Stout, Natasha K. , Stein, Sarah , Corey, Matthew T. , Jushchyshyn, Jessica A., Shah, Ria , Wolfson, Emily A , Mandelblatt, Jeanne S. , Matlock, Daniel D. , Schechter, Clyde B., Harris, Russell, LeStage, Barbara , Schoenborn, Nancy L. , Matlock, Daniel D , Montori, Víctor M. , Richman, Ilana B. , Harris, Russell, Jayasekera, Jinani C.

Mayo Clinic

Journal of the American Geriatrics Society | April 15, 2025 | Volume: 73 | Issue: 7 | Pages: 2188-2195

10.1111/jgs.19466 | PMID 40231782 Get It

ABSTRACT Background Guidelines recommend primary care practitioners (“PCPs”) engage women ≥ 75 years in shared decision‐making (SDM) around mammography screening. Therefore, we aimed to develop a web‐based conversation aid about mammography screening for women ≥ 75 using output from established simulation models to provide screening outcomes based on > 23,000 combinations of individual women's health and breast cancer risk factors. Methods We used an end‐user centered design approach to develop a prototype web‐based conversation aid incorporating feedback. From July 2023 to April 2024, 10 PCPs from a Boston‐area health system and a safety‐net hospital used the prototype aid during encounters with women ≥ 75 without breast cancer or dementia ( n = 30; 1–5 patients per PCP). We observed aid use and assessed clinician effort to involve patients in SDM using OPTION5 (assesses five components of SDM, scores range 0–100). We surveyed PCPs and patients about the aid's acceptability. Patients completed the SDM‐process scale (scores range 0–4) to rate the SDM quality experienced. Participants' comments were subject to thematic analysis. Results Of 10 PCP ‐participants, seven were female and four were community‐based. Of 30 patient‐participants, 22 (73%) were non‐Hispanic White, 9 (30%) had ≥ 2 Charlson comorbidities and mean age was 78.5 years ( SD 2.8). Nine PCPs agreed that the aid helped them with SDM and was easy‐to‐use; six felt it had too much information; and seven planned to continue using the aid. Patients rated the SDM ‐process highly (scores = 3.0 [ SD 0.9]) and we observed high SDM (mean OPTION5 = 77.9 [ SD 20.6]). Participants felt the aid was “empowering” and “helpful for decision‐making.” After SDM discussions, seven patients intended to stop screening, nine to screen less frequently, and 14 to continue screening regularly. Conclusions We developed a novel conversation aid that supports SDM about mammography screening with women ≥ 75 years. Lessons learned will guide revisions of a final tool for testing in a clinical trial.
Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: Association With Drain Days and Seromas
Brown, Samantha , McLaughlin, Sarah A. , Vijayasekaran, Aparna , Li, Zhuo , Price, M, Jakub, James W. , Brown, Samantha J , Forte, Antonio Jorge , Piltin, Mara A. , Price, Monica M, Jakub, James W , Boughey, Judy C. , Forte, Antonio J. , Hieken, Tina J. , Price, Monica M.

Mayo Clinic

The American Surgeon™ | April 15, 2025 | Volume: 91 | Issue: 8 | Pages: 1323-1330

10.1177/00031348251332692 | PMID 40231739 Get It

Background: Immediate lymphatic reconstruction (ILR) via lymphovenous anastomosis is performed in patients undergoing axillary lymph node dissection (ALND) to minimize the risk of lymphedema. Following ALND, drains are placed to prevent seromas, while prolonged drain days are associated with increased risk of infection. The study aim was to determine the impact of ILR on the number of drain days following ALND in patients with breast cancer. Methods: We report a post-hoc analysis of a prospective trial (April 2018-January 2023) comparing patients with breast cancer who underwent ALND with ILR (intervention arm) vs ALND without ILR (control arm). Wilcoxon rank sum test and chi-squared or Fisher’s exact tests compared continuous and categorical variables, respectively. Multivariable quantile regression models evaluated the difference in drain days and days until drain removal criteria were met with covariates adjusted. Results: Data from 214 patients were analyzed (n = 115 interventional arm, n = 99 control arm). The intervention arm had a median of 15 axillary drain days compared to 11 days in the control arm ( P = .001). There was no significant difference between groups when measuring drain days based on the date the drain met removal criteria, rather than actual drain removal date. Seroma incidence was lower in the intervention arm (3.5%) vs the control arm (12.1%) ( P = .017) without a statistical difference in incidence of infection. Conclusion: ALND with ILR does not decrease the number of drain days compared to ALND without ILR in patients with breast cancer, although we found the incidence of seromas to be lower without increase in incidence of infection.
Impact of Point-of-care Allogeneic Red Blood Cell Washing on Markers of Transfusion-related Respiratory Complications: A Phase II Randomized Clinical Trial
Kor, Daryl J. , Norris, Philip J. , Armour, Sarah, Wittwer, Erica D. , Santrach, Paula J., Meade, Laurie, Conn, Chelsea M., Schulte, Phillip J. , Pendegraft, Richard S., Germanio, Clara Di , Podgoreanu, Mihai V. , Meade, Laurie A., Warner, Matthew A. , Armour, Sarah, Welsby, Ian J

Mayo Clinic

Anesthesiology | April 14, 2025 | Volume: 143 | Issue: 1 | Pages: 98-113

10.1097/aln.0000000000005505 | PMID 40227960 Get It

Background: Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are leading causes of transfusion-related morbidity and mortality. Soluble factors in erythrocyte supernatant may increase risk for these complications. The authors hypothesized that point-of-care allogeneic erythrocyte washing may be an effective intervention to mitigate elevations in soluble factors as well as physiologic responses associated with transfusion-associated respiratory complications in the setting of cardiac surgery. Methods: This is a two-center, nonblinded, randomized clinical trial evaluating point-of-care washed versus standard issue allogeneic erythrocyte transfusions administered during or on the day of cardiac surgery. The primary analysis was performed via modified intention to treat. The primary outcomes assessed were changes in intermediate markers of lung injury as well as cardiopulmonary physiologic responses to erythrocyte transfusion. Secondary outcomes included the duration of intensive care unit and hospital stay, durations of mechanical ventilation and oxygen supplementation, presence of TRALI or TACO, and mortality. Results: Among 154 analyzed patients (81 washed, 73 standard issue), the median age was 66 yr, and 77 (50.0%) were women. The median (interquartile range) number of allogeneic erythrocyte units transfused on the day of surgery was 3.0 (2.0 to 5.0) in the washed erythrocyte group and 3.0 (2.0 to 4.0) in the standard issue group (P = 0.13). No between-group differences were identified in any of the assessed recipient lung injury biomarkers (all P values > adjusted alpha). Durations of intensive care unit stay (median [interquartile range], 3.0 [2.0 to 5.0] vs. 3.0 [2.0 to 4.0] days; P = 0.117) and hospital length of stay (12.0 [9.0 to 17.0] vs. 12.0 [9.0 to 17.0] days; P = 0.801) were similar, as were the number of ventilator-free days at day 28 (27.0 [27.0 to 27.0] vs. 27.0 [26.0 to 27.0]; P = 0.699) and oxygen-free days at day 28 (24.0 [19.0 to 26.0] vs. 24.0 [22.0 to 26.0]; P = 0.400). No significant differences were noted in mortality rate or in incidence rates for TRALI, TACO, and acute kidney injury. Conclusions: Among patients undergoing cardiovascular surgery with high risk of erythrocyte transfusion, point-of-care washing of allogeneic erythrocyte transfusions did not mitigate changes in intermediate markers of lung injury or cardiopulmonary physiologic responses to erythrocyte transfusion and was not associated with improved clinical outcomes.
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1 -mutated, metastatic breast cancer
Bachelot, Thomas , Sammons, Sarah , Shen, Sherry , Twelves, Chris, Boruta, Gina, Portman, David, Sammons, Sarah L , Goetz, Matthew P. , Wander, Seth Andrew , Nonneville, Alexandre Tassin de , Gal‐Yam, Einav Nili , Damodaran, Senthil

Mayo Clinic

Future Oncology | April 13, 2025 | Volume: 21 | Issue: 11 | Pages: 1317-1324

10.1080/14796694.2025.2481825 | PMID 40222048 Get It

The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post‐Transplant Outcomes in AL Amyloidosis
Muchtar, Eli , Sanchorawala, Vaishali , Hassan, Hamza , Hegenbart, Ute , Lee, Hans C. , Qazilbash, Muzaffar H. , Kin, Andrew , Zonder, Jeffrey A. , Jacob, Eapen, Dingli, David , Arai, Sally , Chin, Michelle M. , Lentzsch, Suzanne , Magen, Hila , Shkury, Eden , Sarubbi, Caitlin, Landau, Heather , Lee, Hans C , Qazilbash, Muzaffar H , Dispenzieri, Angela , Chakraborty, Rajshekhar , Magen, Hila , Gertz, Morie A , Muchtar, E , Dingli, David , Hegenbart, Ute , Sanchorawala, Vaishali , Hassan, Hamza , Schönland, Stefan , Buadi, Francis K. , Dispenzieri, Angela , Chakraborty, Rajshekhar , Gertz, Morie A.

Mayo Clinic

American Journal of Hematology | April 11, 2025 | Volume: 100 | Issue: 7 | Pages: 1141-1151

10.1002/ajh.27685 | PMID 40214172 Get It

ABSTRACTThe optimal conditioning schedule and CD34+ cell dose for autologous stem cell transplantation (ASCT) for AL amyloidosis is unknown. Patients (n = 1704) who underwent ASCT for AL amyloidosis between 2003 and 2020 in 9 centers were included. Data on melphalan conditioning dose, number of conditioning days, whether a rest day between conditioning and stem cell infusion was given or not, and infused CD34+ cell dose were collected. Full‐dose melphalan (≥ 180 mg/m2) was administered in 63.7% of the patients, and 80.4% had melphalan split into 2‐day conditioning. A rest day (day −1) between the conditioning regimen and stem cell infusion was provided in 52.5% of patients. The median infused CD34+ cell count was 4.7 × 106/kg. An infused CD34+ cell count ≥ 4.5 × 106/kg was associated with a shorter time to neutrophil and platelet engraftment. In a nominal regression analysis, full‐dose melphalan, 1‐day melphalan conditioning, and omitting a rest day between conditioning and stem cell infusion were independent predictors of post‐ASCT higher deep hematological response. The median follow‐up was 8.6 years, and 38% of patients died. Independent predictors of superior overall survival in multivariate Cox regression analysis included full‐dose melphalan, having no rest day, and infused CD34+ cells ≥ 4.5 × 106/kg. Independent predictors of higher day‐100 transplant‐related mortality (TRM) in nominal logistic regression analysis included poorer performance status, NT‐proBNP/BNP ≥ 1800/400 pg/mL, serum albumin < 2.5 g/dL, CD34+ cells < 4.5 × 106/kg, and not having a rest day. In conclusion, 1 day of melphalan conditioning and administration of CD34+ cells ≥ 4.5 × 106/kg are recommended for ASCT in AL amyloidosis.